Companies: 48,687 Total Market Cap: 126813242788645.21

Sun Pharmaceutical Industries Limited

NSE-SUNPHARMA
Healthcare Drug Manufacturers - Specialty & Generic
Rank #396
Market Cap 52.00 B
Volume 27,334.63
Price 21.64
Change (%) 0.16%
Country or region India India

Sun Pharmaceutical Industries Limited's latest marketcap:

52.00 B

As of May 2, 2025, Sun Pharmaceutical Industries Limited's market capitalization has reached $52.00 B. According to our data, Sun Pharmaceutical Industries Limited is the 396th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 52.00 B
Revenue (ttm) 6.10 B
Net Income (ttm) 1.35 B
Shares Out 2.40 B
EPS (ttm) 0.56
Forward PE 36.63
Ex-Dividend Date February 6, 2025
Earnings Date May 22, 2025
Market Cap Chart
Data Updated: May 2, 2025

Sun Pharmaceutical Industries Limited's yearly market capitalization.

Sun Pharmaceutical Industries Limited has seen its market value grow from ₹1,421.25 B to ₹4,418.62 B since 2020, representing a total increase of 210.90% and an annual compound growth rate (CAGR) of 30.00%.
Date Market Cap Change (%)
April 28, 2025 ₹4,418.62 B -2.37%
December 31, 2024 ₹4,525.99 B 49.78%
December 29, 2023 ₹3,021.84 B 25.77%
December 30, 2022 ₹2,402.69 B 18.41%
December 31, 2021 ₹2,029.07 B 42.77%
December 31, 2020 ₹1,421.25 B

Company Profile

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited is a leading generic pharmaceutical company that develops, manufactures, and markets branded and generic formulations, as well as active pharmaceutical ingredients (APIs) globally.

Product Portfolio

The company offers a diverse range of formulations across multiple therapeutic areas, including:

  • Central Nervous System
  • Dermatology & Cardiology
  • Oncology & Neuropsychiatry
  • Gastroenterology & Anti-infectives
  • Diabetology & Pain/Analgesics
  • Vitamins/Minerals/Nutrients
  • Respiratory & Gynaecology
  • Ophthalmology & Orthopaedics
  • Nephrology & Dental Care

Key Offerings

  • APIs: Anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs.
  • Generic Medications: Tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
  • Specialty & OTC Products: Including antiretrovirals and over-the-counter medications.

Company Background

Founded in 1983, Sun Pharmaceutical Industries is headquartered in Mumbai, India, and has established itself as a key player in the global pharmaceutical market.

Frequently Asked Questions

As of May 2, 2025, Sun Pharmaceutical Industries Limited (including the parent company, if applicable) has an estimated market capitalization of $52.00 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Sun Pharmaceutical Industries Limited global market capitalization ranking is approximately 396 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region India
Founded 1983
IPO Date n/a
Employees 43,000
CEO Dilip Shanghvi
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address Sun House
Mumbai, Gujarat 400063
India
People Also Watch
ZTS
157.23 0.16%
ETR-MRK
141.14 0.16%
LON-HLN
529.44 0.16%
TAK
15.33 0.16%